Interestingly, this off-target TdT activity has also been implicated in the development of internal tandem duplication mutations in the fms-like tyrosine kinase 3 gene (FLT3-ITD), which frequently co-occur with NPM1 mutations in AML [58]. This evidence concerns the gene NPM1 and acute myeloid leukemia.